by Andy Rickman | Nov 27, 2019
FCPA whistleblowers who report healthcare companies bribing doctors and government officials may be eligible for a reward under the Dodd-Frank reward program. This post will examine international pharma and medical device corruption and how to identify potential... by Andy Rickman | Aug 23, 2019
Reuters reporter Brad Brooks did a fantastic piece on one of my client’s efforts to stop bribery and corrupt practices in the medical device sector in Brazil. A link to Wednesday’s Reuters article can be found here. The article does an excellent job of chronicling the... by Andy Rickman | May 30, 2019
A Rickman Law Group client was awarded more than $4.5 million last week by the SEC. My Brazilian FCPA whistleblower raised internally issues concerning the company’s use of corrupt distributors to win government business. Bloomberg’s article discussing the award... by Andy Rickman | May 3, 2019
Media outlet Just Anti-Corruption published a detailed article on how a Rickman Law Group client triggered the U.S. government’s $519 million Teva settlement. This could result in a Dodd-Frank reward ranging from $51.9 million to $155.7 million for RLG’s client,... by Andy Rickman | Mar 12, 2019
Andy Rickman was recently quoted in TechCentral discussing the Dodd-Frank Act’s reward program and how tech whistleblowers who report corruption may be entitled to millions in rewards. TechCentral has been leading the reporting on corruption in South Africa’s...